Education
About Us
Working with TipRanks
Follow Us
Sol-Gel Tech (SLGL)
:SLGL
SLGL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.35 - $16.50
Previous CloseN/A
Volume503.92K
Average Volume (3M)40.82K
Market Cap
$19.61M
Enterprise Value$93.79M
Total Cash (Recent Filing)$30.47M
Total Debt (Recent Filing)$1.39M
Price to Earnings (P/E)―
Beta1.63
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.20
Shares Outstanding2,785,762
10 Day Avg. Volume43,793
30 Day Avg. Volume40,819
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.50
Price to Sales (P/S)0.00
P/FCF Ratio-10.92
Enterprise Value/Market Cap4.78
Enterprise Value/Revenue7.84
Enterprise Value/Gross Profit-9.32
Enterprise Value/Ebitda-0.95
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sol-Gel Technologies News
PremiumCompany Announcements
Sol-Gel Technologies Reports Q1 2025 Financial Results
PremiumCompany Announcements
Sol-Gel Technologies Reports Q1 2025 Financial Results
PremiumCompany Announcements
Sol-Gel Technologies Regains Nasdaq Compliance
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.48% Mutual Funds
17.71% Other Institutional Investors
99.52% Public Companies and Individual Investors
SLGL FAQ
What was Sol-Gel Tech’s price range in the past 12 months?
Sol-Gel Tech lowest stock price was $3.35 and its highest was $16.50 in the past 12 months.
What is Sol-Gel Tech’s market cap?
Sol-Gel Tech’s market cap is $19.61M.
When is Sol-Gel Tech’s upcoming earnings report date?
Sol-Gel Tech’s upcoming earnings report date is Aug 07, 2025 which is in 51 days.
How were Sol-Gel Tech’s earnings last quarter?
Sol-Gel Tech released its earnings results on May 23, 2025. The company reported -$3.2 earnings per share for the quarter, missing the consensus estimate of -$1.246 by -$1.954.
Is Sol-Gel Tech overvalued?
According to Wall Street analysts Sol-Gel Tech’s price is currently Overvalued.
Does Sol-Gel Tech pay dividends?
Sol-Gel Tech does not currently pay dividends.
What is Sol-Gel Tech’s EPS estimate?
Sol-Gel Tech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sol-Gel Tech have?
Sol-Gel Tech has 2,785,762 shares outstanding.
What happened to Sol-Gel Tech’s price movement after its last earnings report?
Sol-Gel Tech reported an EPS of -$3.2 in its last earnings report, missing expectations of -$1.246. Following the earnings report the stock price went down -1.172%.
Which hedge fund is a major shareholder of Sol-Gel Tech?
Currently, no hedge funds are holding shares in SLGL
Sol-Gel Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-49.39%
Trailing 12-Months
Asset Growth
-32.19%
Trailing 12-Months
Company Description
Sol-Gel Tech
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.